Investors in Biogen Inc (Symbol: BIIB) saw new options begin trading today, for the April 25th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB options ...

Investors in Biogen Inc (Symbol: BIIB) saw new options become available today, for the April 11th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB ...

The symbol of Biogen Pharmachem Industries Ltd is ... Regime for more savings in new financial year? Not Titan, this is stock is at the top of Jhunjhunwala's portfolio; check details 'Even ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

On Wednesday, Goldman Sachs (NYSE:GS) reiterated its Buy rating on Biogen (NASDAQ:BIIB) with a maintained price target of $290.00. The firm's analysis acknowledged Biogen's ...

There are no important events for this country at this time. Select "All" to see top events in other countries or view all events.

Steward Partners Investment Advisory LLC lessened its holdings in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 31.8% during the 4th quarter, according to its most recent disclosure with the ...

Shares of Biogen Inc. BIIB slipped 2.42% to $140.19 Wednesday, on what proved to be an all-around mixed trading session for ...

Biogen's BIIB short percent of float has risen 3.1% since its last report. The company recently reported that it has 3.88 ...

Despite being forewarned, Wall Street dumped Biogen stock again after Wednesday's Q4 results. Quarterly revenues came in at $2.5bn, up 3% year-on-year, and GAAP EPS came to $1.83, up 7% year-on-year.

Hedge funds have recently bought and sold shares of the stock. Lee Danner & Bass Inc. purchased a new stake in shares of Biogen in the fourth quarter valued at $25,000. Larson Financial Group LLC ...